From the Department of Hematology and Oncology, University Medical Center, Tübingen, Germany; and Department of Hematology and Oncology, University Medical Center, Frankfurt/Main, Germany.
Imatinib is a novel tyrosine kinase inhibitor used for the treatment of Philadelphia chromosome–positive leukemias and other malignancies. Side effects are mostly moderate; however, a dose-dependent hematologic toxicity affecting all hematopoietic lineages is observed clinically. The aim of this study was to investigate the effect of imatinib on normal hematopoietic stem and progenitor cells in vitro. A dose-dependent decrease in proliferation potential was found when CD34+ cells were expanded in serum-free medium supplemented with 6 growth factors and imatinib. Functionally, a decrease in colony-forming capacity was observed under increasing doses of imatinib. However, no such effect on more primitive cobblestone area–forming cells was detectable. Both withdrawal of stem cell factor from our expansion cultures or functional inhibition of c-kit led to a similar degree of inhibition of expansion, whereas the effect of imatinib was substantially greater at all dose levels tested. These data suggest a significant inhibitory effect of imatinib on normal CD34+ progenitor (but not stem) cells that is largely independent of c-kit signaling.
Potent Inhibitory Effect of Sirolimus on Circulating Vascular Progenitor Cells
Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation
Impaired Inhibitory Effect of Interleukin-10 on the Balance Between Matrix Metalloproteinase-9 and Its Inhibitor in Mononuclear Cells From Hyperhomocysteinemic Subjects
Virus-Specific Cytotoxic T Lymphocytes Differentially Express Cell-Surface Leukocyte Immunoglobulin-Like Receptor1, an Inhibitory Receptor for Class I Major Histocompatibility Complex Molecules
Corticoids Normalize Leukocyte Production of Macrophage Migration Inhibitory Factor in Septic Shock
Molecular Mechanism of the Inhibitory Effect of Aldosterone on Endothelial NO Synthase Activity
Sympatho-Inhibitory Action of Endogenous Adrenomedullin Through Inhibition of Oxidative Stress in the Brain
Cardiac Sodium-Calcium Exchanger Is Regulated by Allosteric Calcium and Exchanger Inhibitory Peptide at Distinct Sites
Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules